Evidence map›Paper›PMID 38886410›Full record

ArticleScientific reports2024

Association of blood group O with a recurrent risk for acute lower gastrointestinal bleeding from a multicenter cohort study.

Sho Suzuki, Naoyuki Tominaga, Tomonori Aoki, Eiji Sadashima, Tadashi Miike, Hiroshi Kawakami, Katsumasa Kobayashi, Atsushi Yamauchi, Atsuo Yamada, Jun Omori and 37 more

Abstract readMulticenter Study
PubMed Full text at PMC Publisher
In one paragraph

Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

47 authors.

Sho SuzukiDepartment of Gastroenterology and Hepatology, Center for Digestive Disease and Division of Endoscopy, University of Miyazaki Hospital, Miyazaki, Japan.
Naoyuki TominagaDepartment of Gastroenterology, Saga-Ken Medical Centre Koseikan, Saga, Japan. tominaga-n@koseikan.jp.
Tomonori Aoki *Department of Gastroenterology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Eiji Sadashima *Department of Medical Research Institute, Saga-Ken Medical Centre Koseikan, Saga, Japan.
Tadashi MiikeDepartment of Gastroenterology and Hepatology, Center for Digestive Disease and Division of Endoscopy, University of Miyazaki Hospital, Miyazaki, Japan.
Hiroshi KawakamiDepartment of Gastroenterology and Hepatology, Center for Digestive Disease and Division of Endoscopy, University of Miyazaki Hospital, Miyazaki, Japan.
Katsumasa KobayashiDepartment of Gastroenterology, Tokyo Metropolitan Bokutoh Hospital, Tokyo, Japan.
Atsushi YamauchiDepartment of Gastroenterology and Hepatology, Kitano Hospital, Tazuke Kofukai Medical Research Institute, Osaka, Japan.
Atsuo YamadaDepartment of Gastroenterology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Jun OmoriDepartment of Gastroenterology, Nippon Medical School, Graduate School of Medicine, Tokyo, Japan.
Takashi IkeyaDepartment of Gastroenterology, St Luke's International University, Tokyo, Japan.
Taiki AoyamaDepartment of Gastroenterology, Hiroshima City Asa Citizens Hospital, Hiroshima, Japan.
Yoshinori SatoDivision of Gastroenterology, Department of Internal Medicine, St Marianna University School of Medicine, Kanagawa, Japan.
Takaaki KishinoDepartment of Gastroenterology and Hepatology, Center for Digestive and Liver Diseases, Nara City Hospital, Nara, Japan.
Naoki IshiiDepartment of Gastroenterology, Tokyo Shinagawa Hospital, Tokyo, Japan.
Tsunaki SawadaDepartment of Endoscopy, Nagoya University Hospital, Aichi, Japan.
Masaki MurataDepartment of Gastroenterology, National Hospital Organization Kyoto Medical Center, Kyoto, Japan.
Akinari TakaoDepartment of Gastroenterology, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Tokyo, Japan.
Kazuhiro MizukamiDepartment of Gastroenterology, Oita University, Oita, Japan.
Ken KinjoDepartment of Gastroenterology, Fukuoka University Chikushi Hospital, Fukuoka, Japan.
Shunji FujimoriDepartment of Gastroenterology, Chiba Hokusoh Hospital, Nippon Medical School, Chiba, Japan.
Takahiro UotaniDepartment of Gastroenterology, Japanese Red Cross Shizuoka Hospital, Shizuoka, Japan.
Minoru FujitaDivision of Endoscopy and Ultrasonography, Department of Clinical Pathology and Laboratory Medicine, Kawasaki Medical School General Medical Center, Okayama, Japan.
Hiroki SatoDivision of Gastroenterology, Graduate School of Medical and Dental Sciences, Niigata University, Niigata, Japan.
Toshiaki NarasakaDepartment of Gastroenterology, University of Tsukuba, Ibaraki, Japan.
Junnosuke HayasakaDepartment of Gastroenterology, Toranomon Hospital, Tokyo, Japan.
Tomohiro FunabikiDepartment of Emergency Medicine, Fujita Health University Hospital, Aichi, Japan.
Yuzuru KinjoDepartment of Gastroenterology, Naha City Hospital, Okinawa, Japan.
Akira MizukiDepartment of Internal Medicine, Tokyo Saiseikai Central Hospital, Tokyo, Japan.
Shu KiyotokiDepartment of Gastroenterology, Shuto General Hospital, Yamaguchi, Japan.
Tatsuya MikamiDivision of Endoscopy, Hirosaki University Hospital, Hirosaki, Aomori, Japan.
Ryosuke GushimaDepartment of Gastroenterology and Hepatology, Graduate School of Medical Sciences, Kumamoto University, Kumamoto, Japan.
Hiroyuki FujiiDepartment of Gastroenterology and Hepatology, National Hospital Organization Fukuokahigashi Medical Center, Fukuoka, Japan.
Yuta FuyunoDepartment of Medicine and Clinical Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Takuto HikichiDepartment of Endoscopy, Fukushima Medical University Hospital, Fukushima, Japan.
Yosuke ToyaDivision of Gastroenterology, Department of Internal Medicine, Iwate Medical University, Iwate, Japan.
Kazuyuki NarimatsuDepartment of Internal Medicine, National Defense Medical College, Saitama, Japan.
Noriaki ManabeDivision of Endoscopy and Ultrasonography, Department of Clinical Pathology and Laboratory Medicine, Kawasaki Medical School, Kurashiki, Okayama, Japan.
Koji NagaikeDepartment of Gastroenterology and Hepatology, Suita Municipal Hospital, Osaka, Japan.
Tetsu KinjoDepartment of Endoscopy, University of the Ryukyus Hospital, Okinawa, Japan.
Yorinobu SumidaDepartment of Gastroenterology, National Hospital Organization Kyushu Medical Center, Fukuoka, Japan.
Sadahiro FunakoshiDepartment of Gastroenterological Endoscopy, Fukuoka University Hospital, Fukuoka, Japan.
Kiyonori KobayashiDepartment of Gastroenterology, Kitasato University, School of Medicine, Kanagawa, Japan.
Tamotsu MatsuhashiDepartment of Gastroenterology and Neurology, Akita University Graduate School of Medicine, Akita, Japan.
Yuga KomakiDigestive and Lifestyle Diseases, and Hygiene and Health Promotion Medicine, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, Japan.
Mitsuru KaiseDepartment of Gastroenterology, Nippon Medical School, Graduate School of Medicine, Tokyo, Japan.
Naoyoshi NagataDepartment of Gastroenterological Endoscopy, Tokyo Medical University, Tokyo, Japan. nnagata_ncgm@yahoo.co.jp.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The relationship between blood group and rebleeding in acute lower gastrointestinal bleeding (ALGIB) remains unclear. This study aimed to investigate the association between blood group O and clinical outcomes in patients with ALGIB. The study included 2336 patients with ALGIB whose bleeding source was identified during initial endoscopy (from the CODE BLUE-J Study). The assessed outcomes encompassed rebleeding and other clinical parameters. The rebleeding rates within 30 days in patients with blood group O and those without blood group O were 17.9% and 14.9%, respectively. Similarly, the rates within 1 year were 21.9% for patients with blood group O and 18.2% for those without blood group O. In a multivariate analysis using age, sex, vital signs at presentation, blood test findings, comorbidities, antithrombotic medication, active bleeding, and type of endoscopic treatment as covariates, patients with blood group O exhibited significantly higher risks for rebleeding within 30 days (odds ratio [OR] 1.31; 95% confidence interval [CI] 1.04-1.65; P = 0.024) and 1 year (OR 1.29; 95% CI 1.04-1.61; P = 0.020) compared to those without blood group O. However, the thrombosis and mortality rates did not differ significantly between blood group O and non-O patients. In patients with ALGIB, blood group O has been identified as an independent risk factor for both short- and long-term rebleeding.

Indexed as

ABO Blood-Group SystemGastrointestinal HemorrhageRecurrenceAcute DiseaseAgedCohort StudiesFemaleHumansMaleMiddle AgedRisk FactorsABO Blood-Group System

Identifiers

PMID38886410
PMCPMC11183064

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.